Sino Biopharma’s subsidiary, CTTQ further deepens the exclusive strategic collaboration with GSK: Hong Kong Friday, July 10, 2026, 16:00 Hrs [IST] Sino Biopharmaceutical Limited ...

Sino Biopharmaceutical will receive an upfront payment of $200m from AstraZeneca. The group is also eligible for further ...

In another big-ticket licensing deal with a Chinese biotech, AstraZeneca has claimed rights to a drug candidate for chronic ...

AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & ...

Spread the love“`html For millions of people around the world, inhalers are a lifeline. Whether for managing asthma, COPD, or other respiratory conditions, knowing how to use an inhaler correctly can ...

Respiratory specialists have shared tips for ensuring inhalers are used correctly in a bid to reduce the four deaths caused by asthma every day in the UK.

Credit-market participants may be underestimating the potential recovery from defaults by software-sector companies, and private credit may play a role as well, according to Goldman Sachs. Leveraged ...

Inhalation therapy remains central to pharmacologic treatment for patients with chronic obstructive pulmonary disease, but incorrect inhaler selection and poor inhalation technique remain common ...

Seems like every day there’s a new recall on a food product because of a recalled dry milk powder ingredient linked to possible salmonella contamination. Everything from pork rinds to pizza and from ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--A new study published in the Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation shows how an innovative phone-based inhaler education program ...

Humana Healthcare Research and University of Chicago Medicine study highlights promise of improving respiratory care through remote learning. A new study published in the Chronic Obstructive Pulmonary ...